文献速递心脏核医学

18F-氟他美他莫PET在心脏淀粉样变性中的应用

18F-flutemetamol positron emission tomography in cardiac amyloidosis.
PubMed 文献 · J Nucl Cardiol · 2020-10-06

本研究纳入17例患者(12例心脏淀粉样变性,5例非淀粉样心衰),行18F-氟他美他莫PET/MRI或PET/CT,评估心肌和血池SUV,并行LGE和T1 mapping/ECV。结果显示CA组整体松弛时间和ECV更高,但仅2/12例CA患者PET阳性,最大和平均SUV组间无差异,提示PET诊断敏感性低。

要点

  • 18F-氟他美他莫PET在心脏淀粉样变性中诊断敏感性低,仅2/12例阳性。
  • CA组整体松弛时间和ECV显著高于非淀粉样心衰组。
  • 最大和平均SUV在CA与非淀粉样心衰组间无显著差异。

核心结论

  • 尽管结果支持蛋白非依赖性结合,但18F-氟他美他莫PET对心脏淀粉样变性的诊断敏感性低。

研究设计与样本

  • 纳入17例患者(12例心脏淀粉样变性,5例非淀粉样心衰),行心脏18F-氟他美他莫PET/MRI或PET/CT,评估心肌和血池SUV,并行LGE和T1 mapping/ECV估算。

主要发现

  • CA组整体松弛时间为1448 vs. 1326(P=0.02),ECV为58.9% vs. 33.7%(P=0.006),均高于NA-HF组。
  • 12例CA患者中仅2例PET阳性(分别为AL和ATTR)。
  • 最大SUV为2.21 vs. 1.69(P=0.18),平均SUV为1.73 vs. 1.30(P=0.13),组间无差异。
  • 9例CA患者中8例检出LGE。

临床怎么用

  • 18F-氟他美他莫PET对心脏淀粉样变性诊断敏感性低,临床解读阳性结果需谨慎结合其他检查。

局限性

  • 样本量小(共17例),需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Bone-tracer scintigraphy has an established role in diagnosis of cardiac amyloidosis (CA) as it detects transthyretin amyloidosis (ATTR). Positron emission tomography (PET) with amyloid tracers has shown high sensitivity for detection of both ATTR and light-chain (AL) CA. We aimed to investigate the accuracy of 18F-flutemetamol in CA. METHODS: We enrolled patients with CA or non-amyloid heart failure (NA-HF), who underwent cardiac 18F-flutemetamol PET/MRI or PET/CT. Myocardial and blood pool standardized tracer uptake values (SUV) were estimated. Late gadolinium enhancement (LGE) and T1 mapping/ extracellular volume (ECV) estimation were performed. RESULTS: We included 17 patients (12 with CA, 5 with NA-HF). PET/MRI was conducted in 13 patients, while PET/CT was conducted in 4. LGE was detected in 8 of 9 CA patients. Global relaxation time and ECV were higher in CA (1448 vs. 1326, P = 0.02 and 58.9 vs. 33.7%, P = 0.006, respectively). Positive PET studies were demonstrated in 2 of 12 patients with CA (AL and ATTR). Maximal and mean SUV did not differ between groups (2.21 vs. 1.69, P = 0.18 and 1.73 vs. 1.30, P = 0.13). CONCLUSION: Although protein-independent binding is supported by our results, the diagnostic yield of PET was low. We demonstrate here for the first time the low sensitivity of PET for CA.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Papathanasiou M, Kessler L, Carpinteiro A, et al. 18F-flutemetamol positron emission tomography in cardiac amyloidosis. J Nucl Cardiol. 2020. PMID: 33025472. doi:10.1007/s12350-020-02363-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。